Skip to main content
. 2016 Jun 7;66(649):e587–e592. doi: 10.3399/bjgp16X685705

Table 4.

Comorbidities and drug prescription of 434 patients with panel-confirmed heart failure, divided into those with reduced and preserved ejection fractiona

HFrEF, % (n = 222) HFpEF, % (n = 207) P-value
Mean age, years (SD) 74.5 (11.3) 79.9 (8.7) <0.001
Male sex 57.2 37.7 <0.001

Comorbidities
  Angina pectoris 14.0 23.7 0.10
  Prior myocardial infarction 47.7 16.4 <0.001
  Atrial fibrillation 35.6 62.3 <0.001
  Stroke or TIA 9.9 17.9 0.02
  COPD 20.7 18.8 0.56
  Renal insufficiency (eGFR <30 mL/min/1.73 m2) 9.9 9.7 0.75
  Hypertension 45.5 64.7 <0.001
  Diabetes mellitus 33.3 31.4 0.67

Drug prescriptions
  Diuretics 76.6 73.4 0.45
  ACE inhibitors or ARBs 69.4 53.6 <0.001
  Beta-blockers 59.0 52.7 0.15
  MRAs 31.5 24.6 0.13
  Digoxin 15.3 26.6 0.01
a

Five (1.2%) patients with isolated right-sided HF are not included in this table.

ACE inhibitors = angiotensin-converting enzyme inhibitors. ARB = angiotensin receptor blocker. COPD = chronic obstructive pulmonary disease. eGFR = the calculated glomerular filtration rate according to the modification of diet in renal diseases (MDRD) formula. HFpEF = heart failure with a preserved ejection fraction. HFrEF = heart failure with a reduced ejection fraction. MRAs = mineralocorticoid receptor antagonists. SD = standard deviation. TIA = transient ischaemic attack.